Sept 17 (Reuters) - Novo Nordisk's
experimental Wegovy pill showed a 16.6% weight-loss in a
late-stage study, according to data published in The New England
Journal of Medicine on Wednesday, which is comparable to
previous trial results of injectable Wegovy.
(Reporting by Puyaan Singh in Bengaluru; Editing by Shinjini
Ganguli)